Carlson Sonia, Borrell Luisa N, Eng Celeste, Nguyen Myngoc, Thyne Shannon, LeNoir Michael A, Burke-Harris Nadine, Burchard Esteban G, Thakur Neeta
School of Medicine, University of California, San Francisco, San Francisco, California, United States of America.
Department of Epidemiology & Biostatistics, Graduate School of Public Health and Health Policy, City University of New York, New York, New York, United States of America.
PLoS One. 2017 Jun 13;12(6):e0179091. doi: 10.1371/journal.pone.0179091. eCollection 2017.
Asthma is a multifactorial disease composed of endotypes with varying risk profiles and outcomes. African Americans experience a high burden of asthma and of psychosocial stress, including racial discrimination. It is unknown which endotypes of asthma are vulnerable to racial/ethnic discrimination.
We examined the association between self-reported racial/ethnic discrimination and bronchodilator response (BDR) among African American youth with asthma ages 8 to 21 years (n = 576) and whether this association varies with tumor necrosis factor alpha (TNF-α) level.
Self-reported racial/ethnic discrimination was assessed by a modified Experiences of Discrimination questionnaire as none or any. Using spirometry, BDR was specified as the mean percentage change in forced expiratory volume in one second before and after albuterol administration. TNF-α was specified as high/low levels based on our study population mean. Linear regression was used to examine the association between self-reported racial/ethnic discrimination and BDR adjusted for selected characteristics. An interaction term between TNF-α levels and self-reported racial/ethnic discrimination was tested in the final model.
Almost half of participants (48.8%) reported racial/ethnic discrimination. The mean percent BDR was higher among participants reporting racial/ethnic discrimination than among those who did not (10.8 versus 8.9, p = 0.006). After adjustment, participants reporting racial/ethnic discrimination had a 1.7 (95% CI: 0.36-3.03) higher BDR mean than those not reporting racial/ethnic discrimination. However, we found heterogeneity of this association according to TNF-α levels (p-interaction = 0.040): Among individuals with TNF-α high level only, we observed a 2.78 higher BDR mean among those reporting racial/ethnic discrimination compared with those not reporting racial/ethnic discrimination (95%CI: 0.79-4.77).
We found BDR to be increased in participants reporting racial/ethnic discrimination and this association was limited to African American youth with TNF-α high asthma, an endotype thought to be resistant to traditional asthma medications. These results support screening for racial/ethnic discrimination in those with asthma as it may reclassify disease pathogenesis.
哮喘是一种多因素疾病,由具有不同风险特征和结局的内型组成。非裔美国人承受着哮喘以及包括种族歧视在内的心理社会压力的沉重负担。尚不清楚哮喘的哪些内型易受种族/民族歧视的影响。
我们研究了8至21岁患有哮喘的非裔美国青少年(n = 576)自我报告的种族/民族歧视与支气管扩张剂反应(BDR)之间的关联,以及这种关联是否随肿瘤坏死因子α(TNF-α)水平而变化。
通过修改后的歧视经历问卷将自我报告的种族/民族歧视评估为无或有。使用肺量计,将BDR指定为使用沙丁胺醇前后一秒用力呼气量的平均百分比变化。根据我们的研究人群均值,将TNF-α指定为高/低水平。使用线性回归来研究自我报告的种族/民族歧视与针对选定特征进行调整后的BDR之间的关联。在最终模型中测试了TNF-α水平与自我报告的种族/民族歧视之间的交互项。
几乎一半的参与者(48.8%)报告了种族/民族歧视。报告种族/民族歧视的参与者的平均BDR百分比高于未报告的参与者(10.8对8.9,p = 0.006)。调整后,报告种族/民族歧视的参与者的BDR平均值比未报告种族/民族歧视的参与者高1.7(95%CI:0.36 - 3.03)。然而,我们发现根据TNF-α水平这种关联存在异质性(p交互作用 = 0.040):仅在TNF-α高水平的个体中,我们观察到报告种族/民族歧视的参与者的BDR平均值比未报告种族/民族歧视的参与者高2.78(95%CI:0.79 - 4.77)。
我们发现报告种族/民族歧视的参与者的BDR增加,并且这种关联仅限于TNF-α高水平哮喘的非裔美国青少年,这是一种被认为对传统哮喘药物耐药的内型。这些结果支持对哮喘患者进行种族/民族歧视筛查,因为这可能重新分类疾病发病机制。